[{"address1": "2000 Powell Street", "address2": "Suite 1150, eleventh floor", "city": "Emeryville", "state": "CA", "zip": "94608", "country": "United States", "phone": "510 899 8800", "fax": "510 474 1577", "website": "https://novabay.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "NovaBay Pharmaceuticals, Inc. does not have significant operations. Previously, the company was engaged in the development and sale of eyecare, wound care, and skin care products in the United States and internationally. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Mr. Tommy  Law", "age": 39, "title": "Controller, Interim CFO & Treasurer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 220196, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Justin M. Hall Esq., J.D.", "age": 46, "title": "VP of Business Dev., General Counsel, Chief Compliance Officer, Corporate Secretary & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 365177, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.07, "open": 1.08, "dayLow": 0.995, "dayHigh": 1.0625, "regularMarketPreviousClose": 1.07, "regularMarketOpen": 1.08, "regularMarketDayLow": 0.995, "regularMarketDayHigh": 1.0625, "exDividendDate": 1759190400, "payoutRatio": 0.0, "beta": 0.48, "trailingPE": 0.46086955, "forwardPE": -1.2926829, "volume": 159163, "regularMarketVolume": 159163, "averageVolume": 7160584, "averageVolume10days": 140050, "averageDailyVolume10Day": 140050, "bid": 1.03, "ask": 1.06, "bidSize": 300, "askSize": 300, "marketCap": 6371393, "fiftyTwoWeekLow": 0.46, "fiftyTwoWeekHigh": 4.44, "allTimeHigh": 130156.25, "allTimeLow": 0.36, "priceToSalesTrailing12Months": 0.6514051, "fiftyDayAverage": 1.729, "twoHundredDayAverage": 0.9023, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1876906, "profitMargins": 0.33984002, "floatShares": 4829543, "sharesOutstanding": 6010749, "sharesShort": 514318, "sharesShortPriorMonth": 851068, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0856, "heldPercentInsiders": 0.00093999994, "heldPercentInstitutions": 0.21406001, "shortRatio": 0.63, "shortPercentOfFloat": 0.107, "impliedSharesOutstanding": 6010749, "bookValue": -0.028, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -8511000, "trailingEps": 2.3, "forwardEps": -0.82, "lastSplitFactor": "1:35", "lastSplitDate": 1717113600, "enterpriseToRevenue": 0.192, "enterpriseToEbitda": -0.333, "52WeekChange": 0.5070423, "SandP52WeekChange": 0.1198014, "lastDividendValue": 0.8, "lastDividendDate": 1759190400, "quoteType": "EQUITY", "currentPrice": 1.06, "recommendationKey": "none", "totalCash": 5344000, "totalCashPerShare": 0.918, "ebitda": -5633000, "totalDebt": 1042000, "quickRatio": 2.516, "currentRatio": 2.852, "totalRevenue": 9781000, "debtToEquity": 24.547, "revenuePerShare": 1.712, "returnOnAssets": -0.65269, "returnOnEquity": -4.1378202, "grossProfits": 6481000, "freeCashflow": -3351875, "operatingCashflow": 2695000, "grossMargins": 0.66261, "ebitdaMargins": -0.57591, "operatingMargins": -0.57847, "financialCurrency": "USD", "symbol": "NBY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "NovaBay Pharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1193405400000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.06, "postMarketChange": 0.0, "regularMarketChange": -0.0100001, "regularMarketDayRange": "0.995 - 1.0625", "fullExchangeName": "NYSE American", "averageDailyVolume3Month": 7160584, "fiftyTwoWeekLowChange": 0.5999999, "fiftyTwoWeekLowChangePercent": 1.3043476, "fiftyTwoWeekRange": "0.46 - 4.44", "fiftyTwoWeekHighChange": -3.38, "fiftyTwoWeekHighChangePercent": -0.7612613, "fiftyTwoWeekChangePercent": 50.704227, "dividendDate": 1759104000, "earningsTimestampStart": 1755025200, "earningsTimestampEnd": 1755025200, "earningsCallTimestampStart": 1723581000, "earningsCallTimestampEnd": 1723581000, "isEarningsDateEstimate": true, "corporateActions": [], "postMarketTime": 1762562730, "regularMarketTime": 1762549200, "exchange": "ASE", "messageBoardId": "finmb_32625201", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "longName": "NovaBay Pharmaceuticals, Inc.", "regularMarketChangePercent": -0.93459, "regularMarketPrice": 1.06, "epsTrailingTwelveMonths": 2.3, "epsForward": -0.82, "fiftyDayAverageChange": -0.669, "fiftyDayAverageChangePercent": -0.3869289, "twoHundredDayAverageChange": 0.15769994, "twoHundredDayAverageChangePercent": 0.17477551, "priceToBook": -37.85714, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "NovaBay Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]